Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Aortic insufficiency risk factors
Introduction
Overview
Overview
In the past, the most common risk factor for aortic valvular disease had been the rheumatic fever, with subsequent fibrosis of the scarred valve then leading to retraction of the aortic valve cusps and prevention of their apposition during diastole. In the modern era, a more common risk factor for acquired aortic regurgitation is degenerative disease of the aorta and aortic valve in which case there is calcification and fibrosis of the cusps. Infective endocarditis remains an important risk factor and cause of aortic regurgitation. Congenital conditions such as congenital bicuspid aortic valve or a ventricular septal defect can also result in aortic regurgitation. Patients with bicuspid aortic valve are at increased risk of developing aortic dissection.
Risk Factors
Risk Factors
Risk Factors for Aortic Root Disease
Risk factors for the development of aortic regurgitation due to aortic root disease include:[1][2][3][4][5][6]
- Ankylosing spondylitis
- Aortic dissection
- Arteriosclerosis
- Bechterew’s Disease
- Behcet’s syndrome
- Cystic medial necrosis of the aorta
- Ehlers-Danlos Syndrome
- Giant cell arteritis
- Hypertension
- Idiopathic dilation of the ascending aorta
- Marfan syndrome
- Osteogenesis imperfecta
- Polymyalgia Rheumatica
- Pseudoxanthoma Elasticum
- Psoriatic arthritis
- Reiter’s syndrome
- Relapsing polychondritis
- Senile aortic ectasia and dilation
- Spondyloarthropathy
- Syphilitic aortitis
- Takayasu arteritis
- Trauma
- Ulcerative colitis
- Whipple’s disease
Risk Factors for Aortic Valve Disease
Risk factors for the development of aortic regurgitation due to aortic valve disease include:[2][3][7][8][9] [10]
- Bicuspid aortic valve
- Collagen vascular disease
- Senile or degenerative calcific aortic valve disease
- Endocarditis
- Myxomatous aortic valve
- Rheumatic fever
- Rheumatoid arthritis
- Sinus of Valsalva Aneurysm
- Systemic Lupus Erythematosus
- Trauma
- Marfan Syndrome
- Turner’s Syndrome
- Ventricular Septal Defect
- Weight loss medications
Risk Factors for Acute Aortic Regurgitation
The risk factors for Acute Aortic Regurgitation include the following:[2][3][11][12][13]
Risk Factors for Chronic Aortic Regurgitation
The risk factors for Chronic Aortic Regurgitation include:[5][12][14][15][16] [17]
- Ankylosing Spondylitis
- Aortic Dissection
- Acromegaly
- Arteriosclerosis
- Bacterial Endocarditis
- Bechterew’s Disease
- Bicuspid aortic valve
- Cystic medial necrosis of the aorta
- Ehlers-Danlos Syndrome
- Hypertension
- Marfan Syndrome
- Myxomatous aortic valve
- Polymyalgia Rheumatica
- Pseudoxanthoma Elasticum
- Reiter’s Syndrome
- Rheumatic Fever
- Rheumatoid Arthritis
- Sinus of Valsalva Aneurysm
- Syphilis
- Systemic Lupus Erythematosus
- Turner’s Syndrome
- Ventricular Septal Defect
- Weight loss medications
References
References
- ↑ Enriquez-Sarano M, Tajik AJ (2004). “Clinical practice. Aortic regurgitation”. N Engl J Med. 351 (15): 1539–46. doi:10.1056/NEJMcp030912. PMID 15470217.
- ↑ 2.0 2.1 2.2 Onorati F, De Santo LS, Carozza A, De Feo M, Renzulli A, Cotrufo M (2004). “Marfan syndrome as a predisposing factor for traumatic aortic insufficiency”. The Annals of Thoracic Surgery. 77 (6): 2192–4. doi:10.1016/S0003-4975(03)01409-7. PMID 15172299. Retrieved 2011-03-28. Unknown parameter
|month=ignored (help) - ↑ 3.0 3.1 3.2 Prêtre R, Faidutti B (1993). “Surgical management of aortic valve injury after nonpenetrating trauma”. The Annals of Thoracic Surgery. 56 (6): 1426–31. PMID 8267458. Retrieved 2011-03-28. Unknown parameter
|month=ignored (help) - ↑ Ferreira TF, Freire M, Teodoro RB (2016). “Difficulties in the differential diagnosis between Takayasu arteritis and rheumatic fever: case report”. Rev Bras Reumatol Engl Ed. 56 (1): 90–2. doi:10.1016/j.rbre.2015.07.001. PMID 27267341.
- ↑ 5.0 5.1 Kim, M.; Roman, MJ.; Cavallini, MC.; Schwartz, JE.; Pickering, TG.; Devereux, RB. (1996). “Effect of hypertension on aortic root size and prevalence of aortic regurgitation”. Hypertension. 28 (1): 47–52. PMID 8675263. Unknown parameter
|month=ignored (help) - ↑ Palazzi C, D’ Angelo S, Lubrano E, Olivieri I. Aortic involvement in ankylosing spondylitis. Clin Exp Rheumatol. May-Jun 2008;26(3 Suppl 49):S131-4.
- ↑ Bekeredjian, R.; Grayburn, PA. (2005). “Valvular heart disease: aortic regurgitation”. Circulation. 112 (1): 125–34. doi:10.1161/CIRCULATIONAHA.104.488825. PMID 15998697. Unknown parameter
|month=ignored (help) - ↑ Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). “2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines”. J Am Coll Cardiol. 63 (22): e57–185. doi:10.1016/j.jacc.2014.02.536. PMID 24603191.
- ↑ Ribeiro HB, Orwat S, Hayek SS, Larose É, Babaliaros V, Dahou A; et al. (2016). “Cardiovascular Magnetic Resonance to Evaluate Aortic Regurgitation After Transcatheter Aortic Valve Replacement”. J Am Coll Cardiol. 68 (6): 577–85. doi:10.1016/j.jacc.2016.05.059. PMID 27491900.
- ↑ Schmoldt A, Benthe HF, Haberland G, Raffle A, Gray J, MacDonald HR, Ehrhart IC, Parker PE, Weidner WJ, Dabney JM, Scott JB, Haddy FJ, Gatzy JT (September 1975). “Digitoxin metabolism by rat liver microsomes”. Biochem. Pharmacol. 24 (17): 1639–41. doi:10.1136/bmj.1.6001.93-a. PMC 5922622. PMID 10.
- ↑ Isner JM (1991). “Acute catastrophic complications of balloon aortic valvuloplasty. The Mansfield Scientific Aortic Valvuloplasty Registry Investigators”. Journal of the American College of Cardiology. 17 (6): 1436–44. PMID 2016464. Unknown parameter
|month=ignored (help);|access-date=requires|url=(help) - ↑ 12.0 12.1 Stiles, GL.; Friesinger, GC. (1980). “Bacterial endocarditis with aortic regurgitation: implications of embolism”. South Med J. 73 (5): 582–6. PMID 7375973. Unknown parameter
|month=ignored (help) - ↑ Spagnuolo, M.; Kloth, H.; Taranta, A.; Doyle, E.; Pasternack, B. (1971). “Natural history of rheumatic aortic regurgitation. Criteria predictive of death, congestive heart failure, and angina in young patients”. Circulation. 44 (3): 368–80. PMID 4255488. Unknown parameter
|month=ignored (help) - ↑ Palazzi C, D’ Angelo S, Lubrano E, Olivieri I. Aortic involvement in ankylosing spondylitis. Clin Exp Rheumatol. May-Jun 2008;26(3 Suppl 49):S131-4.
- ↑ Pereira, AM.; van Thiel, SW.; Lindner, JR.; Roelfsema, F.; van der Wall, EE.; Morreau, H.; Smit, JW.; Romijn, JA.; Bax, JJ. (2004). “Increased prevalence of regurgitant valvular heart disease in acromegaly”. J Clin Endocrinol Metab. 89 (1): 71–5. PMID 14715829. Unknown parameter
|month=ignored (help) - ↑ Wunderlich, C.; Schulze, MR.; Strasser, RH. (2005). “Severe aortic regurgitation in Ehlers-Danlos syndrome type IV”. Heart. 91 (1): 126. doi:10.1136/hrt.2004.035097. PMID 15604357. Unknown parameter
|month=ignored (help) - ↑ Pierpont ME, Basson CT, Benson DW, Gelb BD, Giglia TM, Goldmuntz E; et al. (2007). “Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics”. Circulation. 115 (23): 3015–38. doi:10.1161/CIRCULATIONAHA.106.183056. PMID 17519398.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]; Lakshmi Gopalakrishnan, M.B.B.S. [3]; Mohammed A. Sbeih, M.D. [4] ; Usama Talib, BSc, MD [5]